NL-OMON49455已完成不适用
A Phase 1 Trial to Assess the Mass Balance, Absolute Bioavailability, and Pharmacokinetics of 14C ASTX660 in Healthy Volunteers - Mass Balance and Pharmacokinetics of 14C-ASTX660 in Healthy Volunteers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Gender: Male or female
- •Age: 18 to 65 years, inclusive, at screening
- •Body mass index: 18.0 to 30.0 kg/m2, inclusive at screening
排除标准
- •1. Employee of PRA or the Sponsor.
- •2. History of significant drug and/or food allergies.
- •3. Using alcohol in the 48 hours (2 days) prior to screening and each admission
- •to the clinical research center is not allowed.
- •4. Using tobacco products in the 3 months prior to screening.
- •5. Known significant mental illness or other condition, such as active alcohol,
- •or other substance abuse or addiction, that in the opinion of the Investigator
- •predisposes the subject to high risk of noncompliance with the protocol.
- •6. Positive drug and alcohol screen (opiates, methadone, cocaine, amphetamines
- •[including ecstasy], cannabinoids, barbiturates, benzodiazepines, tricyclic
- •antidepressants, and alcohol) at screening and each admission to the clinical
- •research center.
- •See the protocol for the complete overview
研究者
相似试验
已完成
不适用
A Phase 1 Study to Assess the Mass Balance, Absolute Bioavailability, and Pharmacokinetics of 14C-ASTX029 in Healthy Volunteersadvanced solid tumorssolid tumorsNL-OMON51576Astex Pharmaceuticals, Inc.8
已完成
不适用
A Phase 1 Study to Assess the Mass Balance, Excretion, and Pharmacokinetics of [14C]-GBT021601, an Oral Hemoglobin S Polymerization Inhibitor, in Healthy Participantssickle cell disease10038158sickle cell anemiaNL-OMON53865Global Blood Therapeutics, Inc.9
尚未招募
不适用
A Phase 1 Trial to Assess the Mass Balance and Pharmacokinetics of 14C-Guadecitabine in Subjects with AML, MDS, or Solid Tumorsblood- and bone marrow cancer10024324NL-OMON46860Astex Pharmaceuticals, Inc6
已完成
不适用
A PHASE 1 TRIAL TO ASSESS THE MASS BALANCE, ABSOLUTE BIOAVAILABILITY, AND PHARMACOKINETICS OF 14C-E7727 IN HEALTHY VOLUNTEERS >=65 YEARS OF AGEMyelodysplastisch syndroomMDSMyelodysplastic syndromesNL-OMON48473Astex Pharmaceuticals, Inc.8
进行中（未招募）
1 期
OP-724-001 studyHealthy volunteersJPRN-jRCT2031230432Yuushi Haruyama6